Ginsenoside F4

Product Specifications

CAS Number

181225-33-2

Target

Apoptosis|||Bcl-2 Family|||IL Receptor|||MMP

Related Pathways

Immunology/Inflammation|||Proteases/Proteasome|||Apoptosis

Purity

0.9734

Bioactivity

Ginsenoside F4 exerts inhibitory effects on human lymphocytoma JK cells by inducing apoptosis. The mechanism of action involves mitochondrial dysfunction, increased Bax expression, and reduced Bcl-2 expression, together resulting in programmed cell death.

Smiles

C[C@]12[C@@]3(C)[C@@]([C@@H](\C(=C\CC=C(C)C)\C)CC3)([C@H](O)C[C@@]1([C@]4(C)[C@@]([C@@H](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O)[C@@H](CO)O5)C2)(C(C)(C)[C@@H](O)CC4)[H])[H])[H]